Abstract
ì¤ì´ëª¨ìì´í¬ë°ì´ë¬ì¤(CMV)ë ê³ ì¶ì ì¬í í¼í´ë¥¼ 주ë ë°ì´ë¬ì¤ì´ë¤. 2013ë ê³ ì¶ íì¢ ì²ìì ì ë¨ë¶ìì ê´´ì ì¦ìì´ ëíë ì물체ë¡ë¶í° CMV를 ìì ë¶ë¦¬íìê³ ì´ ë¶ë¦¬ì£¼ë¥¼ CMV-GTNì¼ë¡ ëª ëª íìë¤. CMV-GTNê³¼ 기존ì í¹ì±ì´ ì ìë ¤ì§ CMV-Ca-P1ì ëìì¼ë¡ ì¸í¼ë¨ë°±ì§ì ìë¯¸ë ¸ì° ìì´ê³¼ ì¬ë¬ 기주ì물ìì ì물ì ë°ìì ë¹êµíìë¤. CMV-Ca-P1ì ì¸ í¼ë¨ë°±ì§ ìë¯¸ë ¸ì°ì 217ê°ë¡ 구ì±ëì´ ììì¼ë, CMV-GTNì ìë¯¸ë ¸ì° ìì´ 57ë²ì§¸ì ë°ë¦°ì´ ì¶ê°ë 218ê°ë¡ 구ì±ëì´ ììë¤. CMV-GTNê³¼ GeneBankì ë±ë¡ë ë¤ìí CMV ë¶ë¦¬ì£¼ë¤ì ì¸í¼ë¨ë°±ì§ì ì ì ì ì¬ì±ì 96-99%ìë¤. ì물 ê²ì ìì í ë§í ì ê³ ì¶ìì ë³ìì±ì´ ê°íê² ë°íëë CMV-GTNì ê³ ì¶ íì¢ ì ëí ì íì± ì¤í¬ë¦°ì ìíì¬ ì ë°íìë¤. ê³ ì¶ ìí íì¢ 135ì¢ ì ëíì¬ CMV-GTNì¼ë¡ ê²ì íìê³ CMV-Ca-P1ê³¼ ì íì± ë°ìì ë¹êµíìë¤. ê·¸ ê²°ê³¼ CMV-GTNì ëíì¬ ì íì± ë°ìì ííí íì¢ ì íë 미ì, ì¤ë ì íì± íì¢ ì í«ì¤í, ì¹´ì´ì , 굿쵸ì´ì¤ìë¤. íí¸ CMV-Ca-P1ì ëí ì íì± íì¢ ì ë² ë¡ë°ì ì¹´ì´ì ìë¤.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
